Multinational healthcare company Johnson & Johnson (NYSE:JNJ) met Wall Street’s revenue expectations in Q4 CY2024, with sales ...

We recently published a list of 12 Best Defensive Stocks To Buy Right Now. In this article, we are going to take a look at ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

We recently compiled a list of the 10 Most Promising Dividend Stocks According to Hedge Funds. In this article, we are going ...

To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth ...

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the ...

UPS and JNJ present strong dividends and attractive valuations. See why these durable companies are great for a buy-and-hold ...

The company forecast flat to 2% growth in 2025 per share adjusted profit, compared with $1.14 it earned in 2024. Analysts ...

Some might describe Johnson & Johnson's business as boring, but sometimes, that's not such a bad thing. Selling pharmaceutical products is a steady and reliable business even when the economy is ...

Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.

Johnson & Johnson (JNJ) is one of the stocks most watched ... Over the past month, shares of this world's biggest maker of health care products have returned +1.2%, compared to the Zacks S&P ...

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ stock is a Buy.